Brian S. Decker

2.7k total citations · 1 hit paper
44 papers, 1.6k citations indexed

About

Brian S. Decker is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Brian S. Decker has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 12 papers in Pediatrics, Perinatology and Child Health and 11 papers in Pharmacology. Recurrent topics in Brian S. Decker's work include Pharmacogenetics and Drug Metabolism (9 papers), Dialysis and Renal Disease Management (7 papers) and Pharmaceutical studies and practices (7 papers). Brian S. Decker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Dialysis and Renal Disease Management (7 papers) and Pharmaceutical studies and practices (7 papers). Brian S. Decker collaborates with scholars based in United States, United Kingdom and Canada. Brian S. Decker's co-authors include Wolfgang Sadée, Alexander A. Vinks, Daqing Wang, Teri E. Klein, Yijing He, RHN van Schaik, Kelly A. Birdwell, JJ Swen, Catherine M. Stein and JS Leeder and has published in prestigious journals such as Blood, Cancer Research and Kidney International.

In The Last Decade

Brian S. Decker

44 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

2015 499 citations Kelly A. Birdwell, Brian S. Decker et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian S. Decker United States	18	520	417	348	296	194	44	1.6k
Peter I. Pillans Australia	29	329 0.6×	128 0.3×	597 1.7×	123 0.4×	307 1.6×	93	2.2k
Nicolas Picard France	29	697 1.3×	425 1.0×	968 2.8×	62 0.2×	196 1.0×	81	2.5k
Frieder Keller Germany	29	294 0.6×	140 0.3×	208 0.6×	839 2.8×	467 2.4×	160	2.8k
Stein Bergan Norway	26	653 1.3×	216 0.5×	1.1k 3.3×	133 0.4×	158 0.8×	106	2.1k
Ikuko Yano Japan	26	819 1.6×	326 0.8×	539 1.5×	113 0.4×	378 1.9×	170	2.4k
Jung Mi Oh South Korea	24	379 0.7×	182 0.4×	458 1.3×	64 0.2×	130 0.7×	139	1.7k
Sophie L. Stocker Australia	28	448 0.9×	311 0.7×	97 0.3×	543 1.8×	621 3.2×	115	2.6k
Eleonora L. Swart Netherlands	24	279 0.5×	85 0.2×	79 0.2×	63 0.2×	284 1.5×	76	2.0k
Antonio J. Carcas Spain	22	306 0.6×	339 0.8×	132 0.4×	23 0.1×	353 1.8×	116	1.7k
Sarah W. Alander United States	6	1.1k 2.1×	422 1.0×	90 0.3×	31 0.1×	455 2.3×	9	1.9k

Countries citing papers authored by Brian S. Decker

Since Specialization

Citations

This map shows the geographic impact of Brian S. Decker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian S. Decker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian S. Decker more than expected).

Fields of papers citing papers by Brian S. Decker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian S. Decker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian S. Decker. The network helps show where Brian S. Decker may publish in the future.

Co-authorship network of co-authors of Brian S. Decker

This figure shows the co-authorship network connecting the top 25 collaborators of Brian S. Decker. A scholar is included among the top collaborators of Brian S. Decker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian S. Decker. Brian S. Decker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor, Lynne S., Niraj S. Trasi, Hitesh S. Purohit, et al.. (2024). Changes in drug crystallinity in a commercial tacrolimus amorphous formulation result in variable pharmacokinetics. Journal of Pharmaceutical Sciences. 114(1). 313–322. 2 indexed citations

Decker, Brian S., et al.. (2023). Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks. IEEE Access. 11. 56672–56690. 4 indexed citations

Schwantes-An, Tae-Hwi, Sai Liu, Margaret Stedman, et al.. (2019). Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis. American Journal of Nephrology. 49(2). 125–132. 10 indexed citations

Collins, Kimberly S., Victoria M. Pratt, Marelize Swart, et al.. (2018). Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy. Pharmacogenetics and Genomics. 29(1). 18–22. 9 indexed citations

Carpenter, Janet S., Marc B. Rosenman, Mitchell R. Knisely, et al.. (2016). Pharmacogenomically actionable medications in a safety net health care system. PMC. 2 indexed citations

Slaven, James E., Brian S. Decker, Angela D. M. Kashuba, et al.. (2016). Plasma and Intracellular Concentrations in HIV-infected Patients Requiring Hemodialysis Dosed with Tenofovir Disoproxil Fumarate and Emtricitabine. PMC. 1 indexed citations

Rosenman, Marc B., Brian S. Decker, Kenneth D. Levy, et al.. (2016). Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice. Value in Health. 20(1). 54–59. 49 indexed citations

Wang, Xiaoliang, Hongwei Wang, Bing Shen, et al.. (2016). 1-Alpha, 25-dihydroxyvitamin D3 alters the pharmacokinetics of mycophenolic acid in renal transplant recipients by regulating two extrahepatic UDP-glucuronosyltransferases 1A8 and 1A10. Translational research. 178. 54–62.e6. 14 indexed citations

Birdwell, Kelly A., Brian S. Decker, Julia M. Barbarino, et al.. (2015). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Data Archiving and Networked Services (DANS). 63 indexed citations

10.

Decker, Brian S., David S. Goldfarb, Paul I. Dargan, et al.. (2015). Extracorporeal Treatment for Lithium Poisoning. Clinical Journal of the American Society of Nephrology. 10(5). 875–887. 99 indexed citations

11.

Tu, Wanzhu, Brian S. Decker, Zangdong He, et al.. (2015). Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with Hypertension. Journal of General Internal Medicine. 31(1). 30–36. 14 indexed citations

12.

Dunn, Kenneth W., et al.. (2014). Effects of chronic kidney disease on liver transport: quantitative intravital microscopy of fluorescein transport in the rat liver. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 307(12). R1488–R1492. 19 indexed citations

13.

Decker, Brian S., Joanne S. Carpenter, D. A. Flockhart, et al.. (2014). Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System. Clinical Pharmacology & Therapeutics. 96(3). 307–309. 34 indexed citations

14.

Bouchard, Josée, Darren M. Roberts, Louise Roy, et al.. (2014). Principles and Operational Parameters to Optimize Poison Removal with Extracorporeal Treatments. Seminars in Dialysis. 27(4). 371–380. 34 indexed citations

15.

Decker, Brian S., Kalisha O’Neill, Mary Chambers, et al.. (2013). Hemodialysis does not alter in vitro hepatic CYP3A4 and CYP2D6 metabolic activity in uremic serum. Clinical Pharmacology Advances and Applications. 5. 193–193. 3 indexed citations

16.

Decker, Brian S., Ahmed Mohamed, Mary Chambers, et al.. (2012). Gentamicin Pharmacokinetics and Pharmacodynamics during Short-Daily Hemodialysis. American Journal of Nephrology. 36(2). 144–150. 10 indexed citations

17.

Friedman, Allon N., et al.. (2008). Challenges of Treating a 466-Kilogram Man With Acute Kidney Injury. American Journal of Kidney Diseases. 52(1). 140–143. 4 indexed citations

18.

Decker, Brian S., Bruce A. Mueller, & Kevin M. Sowinski. (2007). Drug Dosing Considerations in Alternative Hemodialysis. Advances in Chronic Kidney Disease. 14(3). e17–e26. 13 indexed citations

19.

Hellman, Richard N., et al.. (2006). Elevated Serum Creatinine and a Normal Urinalysis: A Short Differential Diagnosis in the Etiology of Renal Failure. Renal Failure. 28(5). 389–394. 4 indexed citations

20.

Nowrouzezahrai, Derek, Brian S. Decker, & William Bishop. (2005). High-Performance Double-Precision Cosine Generation.. 21(1). 42–48. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact